Antidiabetic combinations

A/P 25/45 Pill - red round

Generic Name: alogliptin/pioglitazone

Pill with imprint A/P 25/45 is Red, Round and has been identified as Oseni 25 mg / 45 mg. It is supplied by Takeda Pharmaceuticals America, Inc.

Oseni is used in the treatment of Diabetes, Type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Oseni 25 mg / 45 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Oseni (Alogliptin and pioglitazone [ al-oh-glip-tin-and-pye-oh-gli-ta-zone ])-A/P 25/45-25 mg / 45 mg-Red-Round

Oseni
Generic Name: alogliptin and pioglitazone [ al-oh-glip-tin-and-pye-oh-gli-ta-zone ]
Imprint: A/P 25/45
Strength: 25 mg / 45 mg
Color: Red
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Antidiabetic combinations
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 64764-0254
Inactive Ingredients: Mannitol, Microcrystalline cellulose, Croscarmellose sodium, Magnesium stearate, Hypromellose 2910 (6 mPa.s), Titanium dioxide, Polyethylene glycol 8000, Magnesium silicate, Lactose monohydrate, Ferric oxide red, Shellac, Butyl alcohol, Alcohol, Ferrosoferric oxide,
Latest News
Related Drugs